東華大學圖書館 |

Abdominal obesity and the endocannabinoid system = from basic aspects to clinical management of related cardiometabolic risk /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Abdominal obesity and the endocannabinoid system/ edited by Jean-Pierre Despr�es, Vincenzo Di Marzo.
其他題名:	from basic aspects to clinical management of related cardiometabolic risk /
其他作者:	Despr�es, Jean-Pierre.
出版者:	New York :Informa Healthcare, : c2009.,
面頁冊數:	xii, 265 p. :ill.
內容註:	1. Abdominal obesity, metabolic syndrome, and risk of cardiovascular disease / Jean-Pierre Despr��e�s and Vincenzo Di Marzo -- 2. Abdominal obesity in type 2 diabetes / Isabelle Lemieux and Jean-Pierre Despr�es -- 3. Obesity and hypertension / Paul Poirier and Caroline Rh�eaume -- 4. Visceral adiposity, liver fat, and atherogenic dyslipidemia / Marja-Riitta Taskinen, Martin Adiels, and Jan Bor�en -- 5. Visceral adiposity and inflammation / Ulf Smith -- 6. Abdominal obesity and alterations in haemostasis-thrombosis / Ir�ene Juhan-Vague and Marie-Christine Alessi -- 7. Physiological and metabolic characteristics of visceral adipocytes / Alain Veilleux and Andr�e Tchernof -- 8. The endocrine function of adipose tissue : implications of visceral obesity for patients with cardiometabolic risk / Max Lafontan -- 9. Free fatty acid metabolism in visceral obesity / Asem Ali and Michael D. Jensen -- 10. Animal models of visceral obesity / Derek M. Huffman and Nir Barzilai -- 11. Insulin sensitivity and visceral adiposity : effects of rimonabant / Joyce M. Richey ... [et al.] -- 12. Physical activity in the management of visceral obesity and related cardiometabolic risk / Peter M. Janiszewski and Robert Ross -- 13. Can we change the lifestyle of high-risk patients? Lessons from the prevention of diabetes trials / Jaakko Tuomilehto and Jaana Lindstr�om -- 14. Can we change the body fat distribution phenotype? Lessons from PPAR agonists / Zubin Punthakee and Hertzel C. Gerstein -- 15. Is there an optimal diet for the management of abdominal obesity and related cardiometabolic risk / Beno�it Lamarche and Caroline Richard -- 16. The EC system and central control of energy balance : the hypothalamus / Vincenzo Di Marzo -- 17. The EC system and central control of energy balance : the nucleus accumbens / Tim C. Kirkham -- 18. The EC system and the HPA axis / Daniela Cota -- 19. The EC system and gut-brain interactions relevant to satiety / Richard Jones, Galina Burdyga, David G. Thompson, and Graham J. Dockray -- 20. The endogenous cannabinoid system in the gastrointestinal tract / Angelo A. Izzo -- 21. The EC system in the adipose tissue and endocrine pancreas / Isabel Matias -- 22. The EC system in the immune system and the inflammatory response / Tracy A. Sherwood and Thomas W. Klein -- 23. The endocannabinoid system in the liver / Ariane Mallat and Sophie Lotersztajn -- 24. The endocannabinoid system and cardiovascular disease / P�al Pacher and George Kunos -- 25. The endocannabinoid system, energy expenditure, and thermogenesis / Luigi Bellocchio, Cristina Cervino, Valentina Vicennati, Renato Pasquali, and Uberto Pagotto -- 26. Effects of dietary fatty acids on endocannabinoid signaling in the brain and peripheral organs / Alvin Berger and Vincenzo Di Marzo -- 27. Endocannabinoid overactivity and abdominal obesity / Vincenzo Di Marzo and Jean-Pierre Despr�es -- 28. CB1 antagonism in the management of abdominal obesity / Luc F. Van Gaal -- 29. Abdominal obesity and the endocannabinoid system CB1 blockade, insulin resistance, and type 2 diabetes / Andr�e J. Scheen -- 30. Abdominal obesity as a therapeutic target to manage the atherogenic dyslipidemia and related metabolic abnormalities / Jean-Pierre Despr�es -- 31. CB1 blockade and hypertension / Luis M. Ruilope -- 32. Future developments 1 : CB1 blockade for weight gain subsequent to smoking cessation / Jaimee L. Heffner and Robert M. Anthenelli -- 33. Future developments 2 : cannabinoid CB1 receptor blockade in weight gain subsequent to psychiatric disorder treatment / Ester Fride, Shimon Rabichev, and Nikolai Gobshtis.
標題:	Obesity - Molecular aspects. -
電子資源:	http://marc.crcnetbase.com/isbn/9781420060850Distributed by publisher. Purchase or institutional license may be required for access.
ISBN:	9781420060850 (ebook : PDF)

Abdominal obesity and the endocannabinoid system = from basic aspects to clinical management of related cardiometabolic risk /
Abdominal obesity and the endocannabinoid systemfrom basic aspects to clinical management of related cardiometabolic risk /[electronic resource] :edited by Jean-Pierre Despr�es, Vincenzo Di Marzo. - New York :Informa Healthcare,c2009. - xii, 265 p. :ill.

Includes bibliographical references and index.

1. Abdominal obesity, metabolic syndrome, and risk of cardiovascular disease / Jean-Pierre Despr��e�s and Vincenzo Di Marzo -- 2. Abdominal obesity in type 2 diabetes / Isabelle Lemieux and Jean-Pierre Despr�es -- 3. Obesity and hypertension / Paul Poirier and Caroline Rh�eaume -- 4. Visceral adiposity, liver fat, and atherogenic dyslipidemia / Marja-Riitta Taskinen, Martin Adiels, and Jan Bor�en -- 5. Visceral adiposity and inflammation / Ulf Smith -- 6. Abdominal obesity and alterations in haemostasis-thrombosis / Ir�ene Juhan-Vague and Marie-Christine Alessi -- 7. Physiological and metabolic characteristics of visceral adipocytes / Alain Veilleux and Andr�e Tchernof -- 8. The endocrine function of adipose tissue : implications of visceral obesity for patients with cardiometabolic risk / Max Lafontan -- 9. Free fatty acid metabolism in visceral obesity / Asem Ali and Michael D. Jensen -- 10. Animal models of visceral obesity / Derek M. Huffman and Nir Barzilai -- 11. Insulin sensitivity and visceral adiposity : effects of rimonabant / Joyce M. Richey ... [et al.] -- 12. Physical activity in the management of visceral obesity and related cardiometabolic risk / Peter M. Janiszewski and Robert Ross -- 13. Can we change the lifestyle of high-risk patients? Lessons from the prevention of diabetes trials / Jaakko Tuomilehto and Jaana Lindstr�om -- 14. Can we change the body fat distribution phenotype? Lessons from PPAR agonists / Zubin Punthakee and Hertzel C. Gerstein -- 15. Is there an optimal diet for the management of abdominal obesity and related cardiometabolic risk / Beno�it Lamarche and Caroline Richard -- 16. The EC system and central control of energy balance : the hypothalamus / Vincenzo Di Marzo -- 17. The EC system and central control of energy balance : the nucleus accumbens / Tim C. Kirkham -- 18. The EC system and the HPA axis / Daniela Cota -- 19. The EC system and gut-brain interactions relevant to satiety / Richard Jones, Galina Burdyga, David G. Thompson, and Graham J. Dockray -- 20. The endogenous cannabinoid system in the gastrointestinal tract / Angelo A. Izzo -- 21. The EC system in the adipose tissue and endocrine pancreas / Isabel Matias -- 22. The EC system in the immune system and the inflammatory response / Tracy A. Sherwood and Thomas W. Klein -- 23. The endocannabinoid system in the liver / Ariane Mallat and Sophie Lotersztajn -- 24. The endocannabinoid system and cardiovascular disease / P�al Pacher and George Kunos -- 25. The endocannabinoid system, energy expenditure, and thermogenesis / Luigi Bellocchio, Cristina Cervino, Valentina Vicennati, Renato Pasquali, and Uberto Pagotto -- 26. Effects of dietary fatty acids on endocannabinoid signaling in the brain and peripheral organs / Alvin Berger and Vincenzo Di Marzo -- 27. Endocannabinoid overactivity and abdominal obesity / Vincenzo Di Marzo and Jean-Pierre Despr�es -- 28. CB1 antagonism in the management of abdominal obesity / Luc F. Van Gaal -- 29. Abdominal obesity and the endocannabinoid system CB1 blockade, insulin resistance, and type 2 diabetes / Andr�e J. Scheen -- 30. Abdominal obesity as a therapeutic target to manage the atherogenic dyslipidemia and related metabolic abnormalities / Jean-Pierre Despr�es -- 31. CB1 blockade and hypertension / Luis M. Ruilope -- 32. Future developments 1 : CB1 blockade for weight gain subsequent to smoking cessation / Jaimee L. Heffner and Robert M. Anthenelli -- 33. Future developments 2 : cannabinoid CB1 receptor blockade in weight gain subsequent to psychiatric disorder treatment / Ester Fride, Shimon Rabichev, and Nikolai Gobshtis.

Mode of access: World Wide Web.

ISBN: 9781420060850 (ebook : PDF)Subjects--Topical Terms:

1359742
Obesity
--Molecular aspects.Index Terms--Genre/Form:

542853
Electronic books.

Abdominal obesity and the endocannabinoid system = from basic aspects to clinical management of related cardiometabolic risk /
LDR:04733cmm 2200253Ia 4500 001 1988211
003 FlBoTFG
005 20130619153825.0
006 m|||||o||d||||||||
007 cr||||
008 150804s2009 nyuad sb 001 0 eng d
020 $a 9781420060850 (ebook : PDF)
035 $a CRC00HE6084PDF
040 $a FlBoTFG $c FlBoTFG
090 $a RC628 $b .A233 2009
092 $a 362.196398 $b A135
245 0 0 $a Abdominal obesity and the endocannabinoid system $h [electronic resource] : $b from basic aspects to clinical management of related cardiometabolic risk / $c edited by Jean-Pierre Despr�es, Vincenzo Di Marzo.
260 $a New York : $b Informa Healthcare, $c c2009.
300 $a xii, 265 p. : $b ill.
504 $a Includes bibliographical references and index.
505 0 $a 1. Abdominal obesity, metabolic syndrome, and risk of cardiovascular disease / Jean-Pierre Despr��e�s and Vincenzo Di Marzo -- 2. Abdominal obesity in type 2 diabetes / Isabelle Lemieux and Jean-Pierre Despr�es -- 3. Obesity and hypertension / Paul Poirier and Caroline Rh�eaume -- 4. Visceral adiposity, liver fat, and atherogenic dyslipidemia / Marja-Riitta Taskinen, Martin Adiels, and Jan Bor�en -- 5. Visceral adiposity and inflammation / Ulf Smith -- 6. Abdominal obesity and alterations in haemostasis-thrombosis / Ir�ene Juhan-Vague and Marie-Christine Alessi -- 7. Physiological and metabolic characteristics of visceral adipocytes / Alain Veilleux and Andr�e Tchernof -- 8. The endocrine function of adipose tissue : implications of visceral obesity for patients with cardiometabolic risk / Max Lafontan -- 9. Free fatty acid metabolism in visceral obesity / Asem Ali and Michael D. Jensen -- 10. Animal models of visceral obesity / Derek M. Huffman and Nir Barzilai -- 11. Insulin sensitivity and visceral adiposity : effects of rimonabant / Joyce M. Richey ... [et al.] -- 12. Physical activity in the management of visceral obesity and related cardiometabolic risk / Peter M. Janiszewski and Robert Ross -- 13. Can we change the lifestyle of high-risk patients? Lessons from the prevention of diabetes trials / Jaakko Tuomilehto and Jaana Lindstr�om -- 14. Can we change the body fat distribution phenotype? Lessons from PPAR agonists / Zubin Punthakee and Hertzel C. Gerstein -- 15. Is there an optimal diet for the management of abdominal obesity and related cardiometabolic risk / Beno�it Lamarche and Caroline Richard -- 16. The EC system and central control of energy balance : the hypothalamus / Vincenzo Di Marzo -- 17. The EC system and central control of energy balance : the nucleus accumbens / Tim C. Kirkham -- 18. The EC system and the HPA axis / Daniela Cota -- 19. The EC system and gut-brain interactions relevant to satiety / Richard Jones, Galina Burdyga, David G. Thompson, and Graham J. Dockray -- 20. The endogenous cannabinoid system in the gastrointestinal tract / Angelo A. Izzo -- 21. The EC system in the adipose tissue and endocrine pancreas / Isabel Matias -- 22. The EC system in the immune system and the inflammatory response / Tracy A. Sherwood and Thomas W. Klein -- 23. The endocannabinoid system in the liver / Ariane Mallat and Sophie Lotersztajn -- 24. The endocannabinoid system and cardiovascular disease / P�al Pacher and George Kunos -- 25. The endocannabinoid system, energy expenditure, and thermogenesis / Luigi Bellocchio, Cristina Cervino, Valentina Vicennati, Renato Pasquali, and Uberto Pagotto -- 26. Effects of dietary fatty acids on endocannabinoid signaling in the brain and peripheral organs / Alvin Berger and Vincenzo Di Marzo -- 27. Endocannabinoid overactivity and abdominal obesity / Vincenzo Di Marzo and Jean-Pierre Despr�es -- 28. CB1 antagonism in the management of abdominal obesity / Luc F. Van Gaal -- 29. Abdominal obesity and the endocannabinoid system CB1 blockade, insulin resistance, and type 2 diabetes / Andr�e J. Scheen -- 30. Abdominal obesity as a therapeutic target to manage the atherogenic dyslipidemia and related metabolic abnormalities / Jean-Pierre Despr�es -- 31. CB1 blockade and hypertension / Luis M. Ruilope -- 32. Future developments 1 : CB1 blockade for weight gain subsequent to smoking cessation / Jaimee L. Heffner and Robert M. Anthenelli -- 33. Future developments 2 : cannabinoid CB1 receptor blockade in weight gain subsequent to psychiatric disorder treatment / Ester Fride, Shimon Rabichev, and Nikolai Gobshtis.
530 $a Also available in print edition.
538 $a Mode of access: World Wide Web.
650 0 $a Obesity $x Molecular aspects. $3 1359742
650 0 $a Abdomen. $2 bidex $3 876514
650 0 $a Cannabinoids. $3 895369
655 7 $a Electronic books. $2 lcsh $3 542853
700 1 $a Despr�es, Jean-Pierre. $3 2123176
700 1 $a Di Marzo, Vincenzo. $3 916674
776 1 $z 9781420060843 (hardcover : alk. paper) $z 1420060848 (hardcover : alk. paper)
856 4 0 $u http://marc.crcnetbase.com/isbn/9781420060850 $q application/PDF $z Distributed by publisher. Purchase or institutional license may be required for access.